News

Published on 28 May 2024 on Insider Monkey via Yahoo Finance

Hedge Funds are Bullish on This Cancer Stock


Article preview image

We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we discuss why hedge funds have sizable positions in Exact Sciences Corporation (NASDAQ:EXAS).

Challenges in the Health Sector

The healthcare industry is considered to be a fairly defensive sector due to its need. According to a World Health Organization report from December 2023, global health spending reached a new high in 2021 at $9.8 trillion or 10.3% of global gross domestic product (GDP). However, spending distribution remained highly unequal, with public health spending increasing worldwide, except in low-income countries where government health spending declined as it relied heavily on external health aid. In 2021, 11% of the global population lived in countries spending less than $50 per person annually on health, while high-income countries spent around $4,000 per capita. Additionally, low-income countries, despite having 8% of the global population, accounted for only 0.24% of global health expenditure. The report states that while there was a significant increase in public spending on health during the peak of the COVID-19 pandemic, this growth is unlikely to be sustained over the long term as countries now focus on economic challenges like slowing growth, high inflation, and increased debt servicing. Dr Bruce Aylward, WHO Assistant Director-General, Universal Health Coverage, Life Course said:

NASDAQ.EXAS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Should Exact Sciences Stock Stay in Your Portfolio Right Now?

Exact Sciences Corporation EXAS is focused on further promoting Cologuard as the standard of care...

Zacks · via Yahoo Finance 8 Jan 2025

Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we ...

Insider Monkey · via Yahoo Finance 19 Nov 2024

EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test

Exact Sciences Corporation EXAS has unveiled data highlighting significant advancements in the...

Zacks · via Yahoo Finance 18 Nov 2024

Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter

Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its...

Insider Monkey · via Yahoo Finance 11 Nov 2024

Exact Sciences Corporation (EXAS): A Buzzing AI Health Stock to Add to Your...

We recently compiled a list of the 10 Buzzing AI Health Stocks. In this article, we are going to...

Insider Monkey · via Yahoo Finance 4 Oct 2024

Should You Believe in the Growth Potential of Exact Sciences Corporation (EXAS)?

Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter...

Insider Monkey · via Yahoo Finance 24 Aug 2024

Exact Sciences Corporation (EXAS) Slipped Over Investors’ Concerns

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second...

Insider Monkey · via Yahoo Finance 24 Jul 2024

Exact Sciences (EXAS) to Showcase Favorable Research Outcome

Exact Sciences Corporation EXAS will present 10 abstracts demonstrating the breadth and depth of ...

Zacks via Yahoo Finance 28 May 2024

Hedge Funds are Bullish on This Cancer Stock

We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this articl...

Insider Monkey via Yahoo Finance 28 May 2024

Is Exact Sciences Corporation (NASDAQ:EXAS) the Gene Therapy Stock with the...

We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...

Insider Monkey · via Yahoo Finance 23 May 2024